Patton Stephana Eilene

CIK 00016982373 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001698237

Recent Transactions

29 trades

Tax Payment
CUTERA INC
COMMON STOCK
2025-02-13$0.42/sh−623→ 77,216 total
Tax Payment
CUTERA INC
COMMON STOCK
2024-11-13$0.36/sh−2,161→ 77,839 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-10-24+37,500→ 147,500 total
Disposition to Issuer
CUTERA INC
Stock Option (Right to Buy)
2024-07-15−25,000→ 0 total
Disposition to Issuer
CUTERA INC
Stock Option (Right to Buy)
2024-07-15−55,000→ 0 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-07-15+55,000→ 55,000 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-07-15+30,000→ 30,000 total
Disposition to Issuer
CUTERA INC
Stock Option (Right to Buy)
2024-07-15−30,000→ 0 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-07-15+25,000→ 25,000 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-05-13+55,000→ 110,000 total
Award
CUTERA INC
COMMON STOCK
2024-03-06+25,000→ 50,000 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-03-06+25,000→ 55,000 total
Award
CUTERA INC
COMMON STOCK
2024-03-06+30,000→ 80,000 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-03-06+30,000→ 30,000 total
Award
CUTERA INC
COMMON STOCK
2024-03-06+25,000→ 25,000 total
Award
Eiger BioPharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-03-12+71,250→ 71,250 total
Award
Eiger BioPharmaceuticals, Inc.
Common Stock
2021-03-12+11,875→ 17,948 total
Award
Eiger BioPharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 total
Award
Eiger BioPharmaceuticals, Inc.
Common Stock
2020-03-05$7.31/sh+820→ 4,820 total
Purchase
Eiger BioPharmaceuticals, Inc.
Common Stock
2019-04-22$11.03/sh+1,000→ 4,000 total
Award
Eiger BioPharmaceuticals, Inc.
Stock Option ( Right to Buy)
2019-03-21+90,000→ 90,000 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-12-18$1.03/sh−9,510→ 34,485 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-12-18−27,500→ 13,750 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-12-18+27,500→ 43,995 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-10-04+13,750→ 21,250 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-10-04$2.22/sh−4,755→ 16,495 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-10-04−13,750→ 41,250 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2018-03-15+125,000→ 125,000 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-08-21$2.58/sh+7,500→ 7,500 total

Companies

Recent Filings

Address

C/O CUTERA, INC. 3240 BAYSHORE BLVD.

BRISBANE, CA, 94005

View on SEC.gov